← All stocks

PTC THERAPEUTICS, INC.

PTCT Scheduled selling only
CIK 0001070081 #1239 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$4.51M
$4.51M on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 11 sales
Net
−$4.51M
$0.00 against sales at will

By person

18 insiders · 11 transactions
27.4×

Matthew B. Klein holds 27.4 times base salary in stock. $26.28M of shares against $958.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew B. Klein last reported holding, valued at $68.45, the price Common Stock was last bought or sold at on the open market here, on 17 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SCHMERTZLER MICHAEL
Director
$4.51M (11) scheduled
−$4.51M
2,796,454
$191.42M
−1.8%
Klein Matthew B.
CHIEF EXECUTIVE OFFICER
383,868
$26.28M
+68.8%
Boulding Mark Elliott
EXEC. VP AND CLO
105,272
$7.21M
+13.9%
Gravier Pierre
CHIEF FINANCIAL OFFICER
83,986
$5.75M
+52.8%
Golden Lee Scott
EVP & CHIEF MEDICAL OFFICER
79,115
$5.42M
+29.3%
Pauwels Eric
CHIEF BUSINESS OFFICER
73,411
$5.02M
+10.3%
Utter Christine Marie
SVP, CHIEF ACCOUNTING OFFICER
70,199
$4.81M
+30.5%
Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER
63,036
$4.31M
−32.7%
Sollie-Zetlmayer Hege Elisabeth
Director
52,526
$3.60M
+12.9%
ZELDIS JEROME B
Director
22,500
$1.54M
+55.2%
STEELE GLENN JR MD PHD
Director
22,500
$1.54M
+55.2%
Smith Mary L.
Director
21,813
$1.49M
+57.9%
Jacobson Allan Steven
Director
21,451
$1.47M
+31.2%
Young Alethia
Director
21,067
$1.44M
+61.2%
SOUTHWELL DAVID P
Director
20,850
$1.43M
+62.3%
Reeve Emma
Director
10,666
$730.09K
−4.8%
Okey Stephanie
Director
8,000
$547.60K
−34.4%
Chutter Jessica Caroline
Director
7,333
$501.94K

No percentages here. This company's share count has moved by a factor of 10.1 over the window, from 8,294,933 to 83,460,802 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
SCHMERTZLER MICHAEL
17 Sep 2026
Director
Sold on a plan indirect
376
$68.45
$25.74K
SCHMERTZLER MICHAEL
17 Sep 2026
Director
Sold on a plan indirect
9,624
$67.83
$652.80K
SCHMERTZLER MICHAEL
16 Sep 2026
Director
Sold on a plan indirect
7,006
$67.35
$471.85K
SCHMERTZLER MICHAEL
16 Sep 2026
Director
Sold on a plan indirect
2,994
$66.58
$199.34K
SCHMERTZLER MICHAEL
10 Sep 2026
Director
Sold on a plan indirect
10,000
$67.34
$673.40K
SCHMERTZLER MICHAEL
9 Sep 2026
Director
Sold on a plan indirect
572
$68.67
$39.28K
SCHMERTZLER MICHAEL
9 Sep 2026
Director
Sold on a plan indirect
9,428
$67.79
$639.12K
SCHMERTZLER MICHAEL
27 Aug 2026
Director
Sold on a plan indirect
610
$72.22
$44.05K
SCHMERTZLER MICHAEL
27 Aug 2026
Director
Sold on a plan indirect
11,890
$71.55
$850.73K
SCHMERTZLER MICHAEL
26 Aug 2026
Director
Sold on a plan indirect
5,626
$73.18
$411.71K
SCHMERTZLER MICHAEL
26 Aug 2026
Director
Sold on a plan indirect
6,874
$72.74
$500.01K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 26 Sep 2016